SVB Wealth’s ANI Pharmaceuticals ANIP Stock Holding History

SVB Wealth’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25	Closed	-$1.67K	–	520
2025 Q1	$1.67K	Buy	+25	New	+$1.49K	﹤0.01%	1268

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

SVB Wealth's ANIP Position: Q2 2025 in Review

SVB Wealth sold out of ANI Pharmaceuticals (ANIP) in Q2 2025, closing a stake of 25 shares — an estimated $1.67K sold.

SVB Wealth first reported a position in ANIP in Q1 2025 and held it in 1 quarter. The position peaked at $1.67K in Q1 2025. 232 funds tracked by Wall St. Rank hold ANIP as of Q2 2025.

SVB Wealth reported no remaining ANI Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
SVB Wealth sold 25 ANI Pharmaceuticals shares in Q2 2025, an estimated $1.67K.
SVB Wealth first reported a position in ANI Pharmaceuticals in Q1 2025 and held it in 1 quarter.
SVB Wealth's ANI Pharmaceuticals position peaked at $1.67K in Q1 2025.
232 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.